First Wave BioPharma, Inc. (FWBI) NASDAQ
2.96
+0.13(+4.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.35M |
| Enterprise Value | 4.61M |
| P/E Ratio | -3.32 |
| PEG Ratio | -0.24 |
| Price/Sales Ratio | 292.13 |
| Price/Book Ratio | 1.28 |
| Enterprise/Revenue | 321.76 |
| Enterprise/EBITDA | -2.88 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -116.65 |
| Operating Margin | -132.64 |
Management Effectiveness
| Return On Assets | -0.18 |
| Return On Equity | -0.19 |
Income Statement
| Revenue | 36,251 |
| Revenue/Share | 0.02 |
| Gross Profit | 0 |
| EBITDA | -7.08M |
| Net Income | -6.55M |
| Diluted EPS | -4.16 |
Balance Sheet
| Total Cash | 385,542 |
| Total Cash/Share | 0.09 |
| Total Debt | 2.49M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 0.16 |
| Book Value Per Share | 6.18 |
Price History
| 52-Week Change | -92.21 |
| 52-Week High | 60 |
| 52-Week Low | 2.33 |
| Moving Average 50 Days | 3.25 |
| Moving Average 200 Days | 5.14 |
Statistics
| Average Volume | 72,481 |
| Shares Outstanding | 2.03M |
| % Held by Institutions | 1.11 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | -0.06 |
| Last Split Factor | 1:20 |
| Last Split Date | December 18, 2023 |
